REG - Indivior PLC - Notice of Results

IndiviorAnnouncement

Thu 14:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250717:nRSQ3873Ra&default-theme=true

RNS Number : 3873R  Indivior PLC  17 July 2025

Indivior to Report Second Quarter 2025 Financial Results and Host Webcast on
July 31(st)

Richmond, VA, July 17, 2025 - Indivior PLC (Nasdaq / LSE: INDV) today
announced that it will report second quarter 2025 financial results on
Thursday, July 31, 2025 at 7:00 a.m. U.S. ET.  Following the release of the
financial results, Joe Ciaffoni, Chief Executive Officer, and other members of
Indivior's leadership team will host a presentation via live webcast at 8:00
a.m. U.S. ET.

Access to the Live Webcast Presentation:

The webcast event and materials can be accessed on the "Investors" section of
the company's website at www.indivior.com (http://www.indivior.com) before the
event begins.

The webcast link: https://edge.media-server.com/mmc/p/ro37758v
(https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fedge.media-server.com%2Fmmc%2Fp%2Fro37758v&data=05%7C02%7Ctimothy.owens%40Indivior.com%7Cf8cfaf051fa342472fe908ddb26938c0%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638862888413890447%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=2N4tUCC65%2FpZxV9jSIKjM8a90jzEeVxH4FbvtfRaGCs%3D&reserved=0)

 

Participants may access the presentation telephonically by registering with
the following link:

https://register-conf.media-server.com/register/BIb74823c247374ec38580055874599386
(https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fregister-conf.media-server.com%2Fregister%2FBIb74823c247374ec38580055874599386&data=05%7C02%7Ctimothy.owens%40Indivior.com%7Cf8cfaf051fa342472fe908ddb26938c0%7Cbed52191489442999db948e4fb29646e%7C1%7C0%7C638862888413934997%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=FVYLf5LBUkFttQu62gDMpze5Dg61wE3W2TNOdPn7uL0%3D&reserved=0)

(Registrants will have an option to be called back directly immediately prior
to the call or be provided a call-in # with a unique pin code following their
registration)

A replay of the presentation will be available at www.indivior.com
(http://www.indivior.com) .

 

About Indivior

Indivior is a global pharmaceutical company working to help change patients'
lives by developing medicines to treat opioid use disorder (OUD). Our vision
is that all patients around the world will have access to evidence-based
treatment for OUD and we are dedicated to transforming OUD from a global human
crisis to a recognized and treated chronic disease. Building on its global
portfolio of OUD treatments, Indivior has a pipeline of product candidates
designed to expand on its heritage in this category. Headquartered
in the United States in Richmond, VA, Indivior employs over 1,000
individuals globally and its portfolio of products is available in over 30
countries worldwide. Visit www.indivior.com (https://www.indivior.com/en)
 to learn more. Connect with Indivior on LinkedIn by
visiting www.linkedin.com/company/indivior
(https://www.linkedin.com/company/indivior/?viewAsMember=true) .

 

 

Contact:

Jason Thompson

Vice President, Investor Relations

Tel: 804-402-7123 or jason.thompson@indivior.com
(mailto:jason.thompson@indivior.com)

 

Tim Owens

Director, Investor Relations

Tel: 804-263-3978 or timothy.owens@indivior.com
(mailto:timothy.owens@indivior.com)

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOREAPXKFSESEFA